By clicking “Let's go!”, you agree to the storage of cookies on your device to improve navigation, analyze website usage, and assist our marketing efforts.
Read our Personal Data Policy for more information.
Project

The Patient’s Parliament

Client

Novartis Sverige

Services

Concept development

Public relations strategy

Public Affairs

Awards

Live Event – IN2 SABRE Awards 2023

Brief

Patients rights have been a hot topic in the healthcare sector for a long time. The Patients Parliament is a unique meeting place where patients are in control of the agenda, with the aim of empowering patients and making their voices heard. The challenge for Patients Parliament 2022 was to ensure that healthcare providers have access to patients health data to make sure patients always receive the best care possible. The theme for this years event was therefore focused on the importance of access to health data regardless of the healthcare provider.

Execution

Narva developed the Patient’s Parliament in 2019, and since then the event has been held yearly. The Patients Parliament is arranged by patient representatives who control the agenda. They form a council group in which they decide the theme and content of the event. In 2022, the concept was updated to focus on one issue: how to ensure healthcare providers always have access to patients health data when needed.

Results

The event attracted great interest from key decision-makers. In 2022 the Patient’s Parliament gathered over 200 participants, including the speaker of the Riksdag, the Minister of Social Affairs, and other prominent social affair experts. More than 40 associations were involved in the event, twice as many as in 2019. Over the years many influential healthcare politicians have returned, and Patients Parliament has been referred to and cited in two different official government reports. The Patients Parliament for Novartis Sweden was named the winner of the international PR competition IN2 SABRE Award 2023 in the Innovation category Live Event.

More work

Odd combinations

Bayer

Not knowing kills

Bayer

Fairness, reliability and transparency

Embracer Group